C9orf72 and amyotrophic lateral sclerosis: Plasma from 86 individuals (48 ALS, 18 asymptomatic C9orf72 repeat expansion carriers (AsymC9), and 20 healthy controls) was analyzed via a multiplexed NULISATM assay that includes 120 neurodegeneration‐associated proteins.